GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanjivani Paranterals Ltd (BOM:531569) » Definitions » Return-on-Tangible-Equity

Sanjivani Paranterals (BOM:531569) Return-on-Tangible-Equity : 23.06% (As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Sanjivani Paranterals Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Sanjivani Paranterals's annualized net income for the quarter that ended in Mar. 2025 was ₹87.4 Mil. Sanjivani Paranterals's average shareholder tangible equity for the quarter that ended in Mar. 2025 was ₹379.2 Mil. Therefore, Sanjivani Paranterals's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2025 was 23.06%.

The historical rank and industry rank for Sanjivani Paranterals's Return-on-Tangible-Equity or its related term are showing as below:

BOM:531569' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -596.94   Med: -33.09   Max: 49.66
Current: 35.84

During the past 13 years, Sanjivani Paranterals's highest Return-on-Tangible-Equity was 49.66%. The lowest was -596.94%. And the median was -33.09%.

BOM:531569's Return-on-Tangible-Equity is ranked better than
89.5% of 905 companies
in the Drug Manufacturers industry
Industry Median: 6.7 vs BOM:531569: 35.84

Sanjivani Paranterals Return-on-Tangible-Equity Historical Data

The historical data trend for Sanjivani Paranterals's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanjivani Paranterals Return-on-Tangible-Equity Chart

Sanjivani Paranterals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only Negative Tangible Equity Negative Tangible Equity Negative Tangible Equity 49.66 24.60

Sanjivani Paranterals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.04 24.57 28.78 23.80 23.06

Competitive Comparison of Sanjivani Paranterals's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Sanjivani Paranterals's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanjivani Paranterals's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanjivani Paranterals's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Sanjivani Paranterals's Return-on-Tangible-Equity falls into.


;
;

Sanjivani Paranterals Return-on-Tangible-Equity Calculation

Sanjivani Paranterals's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=80.943/( (278.988+379.178 )/ 2 )
=80.943/329.083
=24.60 %

Sanjivani Paranterals's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=87.444/( (0+379.178)/ 1 )
=87.444/379.178
=23.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Sanjivani Paranterals  (BOM:531569) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Sanjivani Paranterals Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Sanjivani Paranterals's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanjivani Paranterals Business Description

Traded in Other Exchanges
N/A
Address
Asha Nagar Park Road, 1202, B-Wing, O2 Business Commercial Park, Mulund (West), Mumbai, MH, IND, 400080
Sanjivani Paranterals Ltd is a pharmaceutical company principally engaged in providing pharmaceutical products and services. The company's main product range includes oral solids and small-volume parenteral and sterile powder formulations. The products offered by the company are anti-biotic, anti-emetic, anti-tuberculosis, anti-diabetic, anti-malarial, anti-fungal, calcium and vitamin, multivitamin, sedative, cardiovascular, anti-gout, and others. The company also provides Liquid Injection, Dry powder Injection, Capsules, Drops, and others. The firm sells its products in India and internationally.

Sanjivani Paranterals Headlines

No Headlines